The 2024 ISPE Biotechnology Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on the evolving landscape and future of the development and manufacturing of biotechnology products.
This conference will focus on unique challenges associated with innovative pharmaceutical products applied and transferred to the (new) biosimilar, bio better, and follow-up biotechnology products, like cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based product development and new applications. In addition, the conference will feature presentations with a focus on enablers for process development, speed-to-market, sustainability, product technology transfer, new concepts for control strategy, and manufacturing.
Throughout this event, we will discuss and consider key areas and advancements in biotechnology:
AI can potentially streamline various operational processes via enhanced automation. Explore the impact of automation and augmentation on innovative processes like ATMPs and gene therapy, redefining how we work.
There is more data to analyze than ever before. A top priority for companies includes finding ways to increase automation, data accessibility, and speed. Learn how to utilize data science in biopharmaceutical tech transfer and process characterization, and how to address challenges and regulatory expectations.
Delve into innovative strategies and technologies to increase sustainability and reduce the environmental impact of the biopharmaceutical industry.
Discover the added value of digitalized Quality Management in ensuring the effectiveness and compliance of quality systems, for reduced inspection risks, and support for a more reliable drug supply chain.
Uncover technological advancements in pharmaceutical manufacturing, including the expedited production of innovative therapies and the integration of robotics and single-use systems to meet current regulatory demands.
Dive into strategies for accelerating commercialization and time-to-market through the product life cycle. The conference will feature approaches aimed at reducing development cycles and enhancing the introduction of processes into facilities.
Explore the challenges, trends, and driving factors behind Biopharmaceutical Facility Design, such as facility planning considerations, economic viability, and regulatory requirements from a CCS and QRM perspective.
Expert Insights: Hear from industry leaders and regulators who will share their perspectives on the future of pharmaceuticals.
The 2024 Biotechnology Conference program committee is requesting proposals aligning with the following content areas: